3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
8
Gastrointestinal
8
Sarcoma
4
Gynecologic
4
Genitourinary
4
Lymphoid
3
Breast
3
Thoracic
2
Head & Neck
2
Tumor-Agnostic
1
Myeloid
1
Endocrine
1
Conditions
Thrombocytosis
1
Neoplasms
1
Myeloproliferative Disorders
1
Leukemia
1
Interventions
Blood Specimen Collection
15
Imatinib Mesylate
10
Flow Cytometry
10
nilotinib
8
Surveys and Questionnaires
8
Polymerase Chain Reaction
8
ponatinib
6
Cytogenetic Analysis
6
ruxolitinib
5
bosutinib
5
Psychiatric Rehabilitation
5
Dasatinib
5
Therapeutics
4
Interviews as Topic
4
Biopsy
4
asciminib
3
Observation
3
Microarray Analysis
3
In Situ Hybridization, Fluorescence
3
Immunoenzyme Techniques
3
Amplified Fragment Length Polymorphism Analysis
3
olverembatinib
2
fludarabine
2
Watchful Waiting
2
Tyrosine Kinase Inhibitors
2
Molecular Diagnostic Techniques
2
Influenza Vaccines
2
Immunologic Techniques
2
Immunohistochemistry
2
Hydroxyurea
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Base Sequence
×
Myeloid
×
Clear all
NCT06246006
2024-02-07
MPL - NPM
Centre Hospitalier Universitaire de NÄ«mes
Unknown
30 enrolled